CO5690570A2 - Nueva combinacion sinergistica que comprende roflumilast y formoterol - Google Patents
Nueva combinacion sinergistica que comprende roflumilast y formoterolInfo
- Publication number
- CO5690570A2 CO5690570A2 CO05062787A CO05062787A CO5690570A2 CO 5690570 A2 CO5690570 A2 CO 5690570A2 CO 05062787 A CO05062787 A CO 05062787A CO 05062787 A CO05062787 A CO 05062787A CO 5690570 A2 CO5690570 A2 CO 5690570A2
- Authority
- CO
- Colombia
- Prior art keywords
- formoterol
- roflumilast
- daily dose
- combined use
- combination including
- Prior art date
Links
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 title abstract 7
- 229960002848 formoterol Drugs 0.000 title abstract 7
- MNDBXUUTURYVHR-UHFFFAOYSA-N roflumilast Chemical compound FC(F)OC1=CC=C(C(=O)NC=2C(=CN=CC=2Cl)Cl)C=C1OCC1CC1 MNDBXUUTURYVHR-UHFFFAOYSA-N 0.000 title abstract 7
- 229960002586 roflumilast Drugs 0.000 title abstract 7
- 239000011885 synergistic combination Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 3
- 208000018569 Respiratory Tract disease Diseases 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02026505 | 2002-11-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5690570A2 true CO5690570A2 (es) | 2006-10-31 |
Family
ID=32338002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO05062787A CO5690570A2 (es) | 2002-11-27 | 2005-06-27 | Nueva combinacion sinergistica que comprende roflumilast y formoterol |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20060142308A1 (https=) |
| EP (1) | EP1567139B1 (https=) |
| JP (1) | JP2006508994A (https=) |
| KR (1) | KR101071798B1 (https=) |
| CN (1) | CN100346777C (https=) |
| AT (1) | ATE399543T1 (https=) |
| AU (1) | AU2003292120B2 (https=) |
| BR (1) | BR0316451A (https=) |
| CA (1) | CA2506962C (https=) |
| CO (1) | CO5690570A2 (https=) |
| CY (1) | CY1110369T1 (https=) |
| DE (1) | DE60321953D1 (https=) |
| DK (1) | DK1567139T3 (https=) |
| EA (1) | EA009935B1 (https=) |
| ES (1) | ES2309357T3 (https=) |
| HR (1) | HRP20050579B1 (https=) |
| IL (1) | IL168308A (https=) |
| IS (1) | IS2575B (https=) |
| MA (1) | MA27539A1 (https=) |
| ME (1) | ME00489B (https=) |
| MX (1) | MXPA05005437A (https=) |
| NO (1) | NO334247B1 (https=) |
| NZ (1) | NZ540659A (https=) |
| PL (1) | PL216752B1 (https=) |
| PT (1) | PT1567139E (https=) |
| RS (1) | RS51081B (https=) |
| SI (1) | SI1567139T1 (https=) |
| TN (1) | TNSN05131A1 (https=) |
| UA (1) | UA83018C2 (https=) |
| WO (1) | WO2004047829A1 (https=) |
| ZA (1) | ZA200503308B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| ES2335498T3 (es) | 2003-03-10 | 2010-03-29 | Nycomed Gmbh | Nuevo proceso para la preparacion de reflumilast. |
| US8663694B2 (en) * | 2005-03-16 | 2014-03-04 | Takeda Gmbh | Taste masked dosage form containing roflumilast |
| DE102005030733A1 (de) * | 2005-07-01 | 2007-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff |
| ES2443342T3 (es) * | 2006-07-05 | 2014-02-19 | Takeda Gmbh | Combinación de inhibidor de la HMG-CoA reductasa rosuvastatina con un inhibidor de la fosfodiesterasa 4, tal como roflumilast, roflumilast-N-óxido para el tratamiento de enfermedades pulmonares inflamatorias |
| WO2013077830A1 (en) * | 2011-11-25 | 2013-05-30 | Mahmut Bilgic | Synergistilly active combinations of roflumilast and carmoterol |
| US20130172303A1 (en) * | 2012-01-03 | 2013-07-04 | Forest Laboratories Holdings Ltd. | Roflumilast compositions for the treatment of copd |
| HUE052275T2 (hu) * | 2013-01-28 | 2021-04-28 | Incozen Therapeutics Pvt Ltd | Eljárások autoimmun, légzõszervi és gyulladásos rendellenességek kezelésére roflumilaszt N-oxid inhalálásával |
| CN104800214A (zh) * | 2014-01-27 | 2015-07-29 | 成都英诺新科技有限公司 | 一种罗氟司特吸入气雾剂复方及制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| DE59410119D1 (de) * | 1993-07-02 | 2002-06-20 | Byk Gulden Lomberg Chem Fab | Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren |
| AU734122B2 (en) * | 1997-02-17 | 2001-06-07 | Takeda Gmbh | Compositions for the treatment of ARDS or IRDS containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4- (difluoromethoxy)benzamide and lung surfactant |
| US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
| ES2302350T3 (es) * | 1997-02-28 | 2008-07-01 | Nycomed Gmbh | Combinacion sinergica de inhibidores de pde y agonistas de adenilatociclasa o agonistas de guanililciclasa. |
| BR9913152A (pt) * | 1998-08-26 | 2001-05-15 | Smithkline Beecham Corp | Terapias para tratamento de doenças pulmonares |
| US6303145B2 (en) * | 1999-05-10 | 2001-10-16 | Sepracor Inc. | (S,R) formoterol methods and compositions |
| CA2715683A1 (en) * | 1999-08-21 | 2001-03-01 | Nycomed Gmbh | Synergistic combination |
| GB0103630D0 (en) * | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
| ES2296923T3 (es) * | 2001-03-22 | 2008-05-01 | Glaxo Group Limited | Derivados formanilidas como agonistas del adrenorreceptor beta2. |
| KR100831534B1 (ko) * | 2001-04-30 | 2008-05-22 | 글락소 그룹 리미티드 | 17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체 |
-
2003
- 2003-11-26 DK DK03767663T patent/DK1567139T3/da active
- 2003-11-26 EA EA200500774A patent/EA009935B1/ru not_active IP Right Cessation
- 2003-11-26 MX MXPA05005437A patent/MXPA05005437A/es active IP Right Grant
- 2003-11-26 RS YUP-2005/0382A patent/RS51081B/sr unknown
- 2003-11-26 AU AU2003292120A patent/AU2003292120B2/en not_active Ceased
- 2003-11-26 PL PL377732A patent/PL216752B1/pl unknown
- 2003-11-26 ES ES03767663T patent/ES2309357T3/es not_active Expired - Lifetime
- 2003-11-26 CA CA2506962A patent/CA2506962C/en not_active Expired - Fee Related
- 2003-11-26 EP EP03767663A patent/EP1567139B1/en not_active Expired - Lifetime
- 2003-11-26 PT PT03767663T patent/PT1567139E/pt unknown
- 2003-11-26 JP JP2004554480A patent/JP2006508994A/ja active Pending
- 2003-11-26 AT AT03767663T patent/ATE399543T1/de active
- 2003-11-26 DE DE60321953T patent/DE60321953D1/de not_active Expired - Lifetime
- 2003-11-26 WO PCT/EP2003/013275 patent/WO2004047829A1/en not_active Ceased
- 2003-11-26 ME MEP-2008-782A patent/ME00489B/me unknown
- 2003-11-26 KR KR1020057009210A patent/KR101071798B1/ko not_active Expired - Fee Related
- 2003-11-26 US US10/535,816 patent/US20060142308A1/en not_active Abandoned
- 2003-11-26 CN CNB2003801037450A patent/CN100346777C/zh not_active Expired - Fee Related
- 2003-11-26 UA UAA200505966A patent/UA83018C2/uk unknown
- 2003-11-26 BR BR0316451-9A patent/BR0316451A/pt not_active IP Right Cessation
- 2003-11-26 HR HRP20050579AA patent/HRP20050579B1/hr not_active IP Right Cessation
- 2003-11-26 SI SI200331344T patent/SI1567139T1/sl unknown
- 2003-11-26 NZ NZ540659A patent/NZ540659A/en not_active IP Right Cessation
-
2005
- 2005-04-25 ZA ZA200503308A patent/ZA200503308B/en unknown
- 2005-05-01 IL IL168308A patent/IL168308A/en not_active IP Right Cessation
- 2005-05-10 TN TNP2005000131A patent/TNSN05131A1/en unknown
- 2005-06-16 MA MA28343A patent/MA27539A1/fr unknown
- 2005-06-17 NO NO20052999A patent/NO334247B1/no not_active IP Right Cessation
- 2005-06-20 IS IS7898A patent/IS2575B/is unknown
- 2005-06-27 CO CO05062787A patent/CO5690570A2/es not_active Application Discontinuation
-
2008
- 2008-09-17 CY CY20081101017T patent/CY1110369T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Smith et al. | Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991 | |
| CU23468B7 (es) | Forma de dosificación de pramipexol en una dosis única diaria | |
| ES2202265T3 (es) | Aerosol medicamentoso en el tratamiento o la prevencion del dolor. | |
| BR0108730A (pt) | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados | |
| ES2123576T3 (es) | Medicamentos. | |
| Choi et al. | Topical agents: a thoughtful choice for multimodal analgesia | |
| ES2162927T3 (es) | Formulacion para la aplicacion por inhalacion. | |
| AR101593A2 (es) | Formulación superfina de formoterol | |
| RU2010105122A (ru) | Композиции для ухода за полостью рта, продукты и способы применения | |
| CO5611092A2 (es) | Formulacion superfina de formoterol | |
| CO6150188A2 (es) | Uso de teencteplasa para tratar un ictus isquemico agudo | |
| CO6220969A2 (es) | Adminsitracion semanal de inhibidores de peptidasa de dipeptidilo | |
| BR112017026417B1 (pt) | Formulação para o tratamento de distúrbios da boca, garganta e vias respiratórias | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| CO5690570A2 (es) | Nueva combinacion sinergistica que comprende roflumilast y formoterol | |
| AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
| CO5540290A2 (es) | Composicion que comprende un inhibidor de pde-4 y antagonista del receptor-hi y su uso en la manufactura de un medicamento para el tratamiento de enfermedades respiratorias | |
| GB2430623A (en) | Medicaments for treating chronic respiratory disease | |
| ES2175663T3 (es) | Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis. | |
| JPH09500610A (ja) | 経鼻芳香放出組成物 | |
| Ko et al. | Effects of topical O24 essential oils on patients with fibromyalgia syndrome: a randomized, placebo controlled pilot study | |
| AR065139A1 (es) | Medicamento para el tratamiento de la endometriosis | |
| BRPI0518741A2 (pt) | uso de uma combinaÇço de uma droga diretamente metabolizada por ugt1a1 ou um seu sal farmaceuticamente aceitÁvel e atazanavir ou um seu sal farmaceuticamente aceitÁvel, e, combinaÇço farmacÊutica para administraÇço oral a um mamÍfero | |
| MX384760B (es) | Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco y gabapentina para el tratamiento del dolor neuropático. | |
| UY26595A1 (es) | Formulaciones de entecavir de dosis bajas y uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |